Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

10 structures for P24864

Entry ID Method Resolution Chain Position Source
1W98 X-ray 215 A B 96-378 PDB
5L2W X-ray 280 A B 96-378 PDB
7KJS X-ray 219 A B 96-378 PDB
7XQK X-ray 225 A B 96-378 PDB
8H4R X-ray 275 A B 96-378 PDB
8H6P X-ray 244 A B 103-373 PDB
8H6T X-ray 300 A B 102-373 PDB
8VQ3 X-ray 184 A B 96-378 PDB
8VQ4 X-ray 190 A B 96-378 PDB
AF-P24864-F1 Predicted AlphaFoldDB

282 variants for P24864

Variant ID(s) Position Change Description Diseaes Association Provenance
CA405260898
rs1599594280
2 P>L No ClinGen
Ensembl
CA307135774
rs995865961
2 P>S No ClinGen
TOPMed
gnomAD
CA307135775
rs1014086924
5 R>L No ClinGen
TOPMed
gnomAD
CA405260928
rs1392000524
7 E>K No ClinGen
TOPMed
rs1284831314
CA405260937
8 R>P No ClinGen
gnomAD
rs1284831314
CA405260936
8 R>Q No ClinGen
gnomAD
CA307135776
rs765558494
8 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs377233800
CA9352090
9 D>H No ClinGen
ESP
ExAC
gnomAD
CA307135788
rs377233800
9 D>Y No ClinGen
ESP
ExAC
gnomAD
rs1242761919
CA405260960
10 A>V No ClinGen
TOPMed
rs1357182033
CA405260971
12 E>K No ClinGen
gnomAD
CA405260981
rs1244850159
13 R>Q No ClinGen
gnomAD
rs752180309
CA9352094
16 M>R No ClinGen
ExAC
TOPMed
gnomAD
CA9352095
rs752180309
16 M>T No ClinGen
ExAC
TOPMed
gnomAD
rs1305959499
CA405261013
18 E>K No ClinGen
TOPMed
rs1469198229
CA405261023
19 D>A No ClinGen
TOPMed
gnomAD
CA405261024
rs1469198229
19 D>G No ClinGen
TOPMed
gnomAD
rs749906913
CA9352097
19 D>H No ClinGen
ExAC
TOPMed
gnomAD
CA405261028
rs1409795988
20 G>S No ClinGen
TOPMed
gnomAD
CA405261034
rs1275105376
21 G>S No ClinGen
TOPMed
gnomAD
CA9352099
rs779694639
21 G>V No ClinGen
ExAC
gnomAD
rs578227778
CA307135790
22 A>G No ClinGen
1000Genomes
gnomAD
CA9352100
rs749045990
22 A>T No ClinGen
ExAC
gnomAD
CA405261042
COSM474498
rs578227778
22 A>V kidney Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
1000Genomes
NCI-TCGA
gnomAD
rs778672861
CA9352102
24 F>L No ClinGen
ExAC
gnomAD
CA9352104
rs771972554
25 S>L No ClinGen
ExAC
TOPMed
gnomAD
CA405261065
rs1250060364
26 A>S No ClinGen
TOPMed
CA9352105
rs776712074
27 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs776712074
CA405261070
27 R>G No ClinGen
ExAC
gnomAD
CA9352106
rs745919586
27 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs745919586
CA405261071
27 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA9352107
rs145289511
28 S>F No ClinGen
ESP
ExAC
CA405261089
rs1205916639
30 K>R No ClinGen
gnomAD
CA405261093
rs1443126704
31 R>G No ClinGen
gnomAD
CA405261108
rs1437724105
33 A>T No ClinGen
gnomAD
CA405261112
rs1186891855
33 A>V No ClinGen
gnomAD
rs763083338
CA9352109
34 N>K No ClinGen
ExAC
gnomAD
CA9352110
rs369751087
35 V>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA405261127
rs1355673586
36 T>A No ClinGen
TOPMed
CA405261129
rs1472595244
36 T>N No ClinGen
gnomAD
rs774836905
CA9352111
37 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA405261132
rs774836905
37 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs772724283
CA9352140
38 F>L No ClinGen
ExAC
gnomAD
rs1225643119
CA405261171
41 D>N No ClinGen
gnomAD
CA405261176
rs1280453007
41 D>V No ClinGen
TOPMed
rs146376659
CA405261183
42 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA9352142
rs146376659
42 P>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs759252695
CA9352145
43 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs765951124
CA9352143
43 D>G No ClinGen
ExAC
gnomAD
rs765951124
CA9352144
43 D>V No ClinGen
ExAC
gnomAD
rs1490679833
CA405261196
44 E>D No ClinGen
gnomAD
rs764828115
CA9352146
46 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA405261223
rs1260554501
COSM994394
48 K>T Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
CA405261234
rs1426540908
49 I>M No ClinGen
TOPMed
gnomAD
CA405261237
rs1195034768
50 D>H No ClinGen
gnomAD
CA405261236
rs1195034768
50 D>N No ClinGen
gnomAD
CA405261235
rs1195034768
50 D>Y No ClinGen
gnomAD
rs1225873654
CA405261245
51 R>K No ClinGen
gnomAD
rs879397969
CA405261253
52 T>K No ClinGen
TOPMed
gnomAD
rs879397969
CA307135804
52 T>M No ClinGen
TOPMed
gnomAD
rs35886256
CA9352148
54 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs1363796932
CA405261277
56 Q>* No ClinGen
gnomAD
CA405261300
rs1384503695
59 S>N No ClinGen
gnomAD
rs1298185322
CA405261305
60 Q>K No ClinGen
gnomAD
CA405261458
rs1161685345
61 P>T No ClinGen
gnomAD
rs374431756
CA405261506
63 D>E No ClinGen
1000Genomes
ExAC
gnomAD
CA9352173
rs779134402
63 D>Y No ClinGen
ExAC
TOPMed
gnomAD
rs141877912
CA9352175
64 N>D No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA9352176
rs778224499
64 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs201174024
CA9352177
65 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs771474736
CA9352178
66 A>T No ClinGen
ExAC
gnomAD
rs776946024
CA9352179
68 C>F No ClinGen
ExAC
TOPMed
gnomAD
CA405261574
rs1288643920
68 C>W No ClinGen
gnomAD
CA405261568
rs776946024
68 C>Y No ClinGen
ExAC
TOPMed
gnomAD
rs998966219
CA307136313
69 A>V No ClinGen
Ensembl
CA9352180
rs746361520
70 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs769333246
CA9352181
71 P>T No ClinGen
ExAC
gnomAD
CA9352183
rs762615251
73 S>F No ClinGen
ExAC
gnomAD
CA9352185
rs774197405
74 L>P No ClinGen
ExAC
gnomAD
rs1184407047
CA405261698
78 P>T No ClinGen
TOPMed
gnomAD
CA9352187
rs767327617
79 D>G No ClinGen
ExAC
gnomAD
rs1240513553
CA405261712
79 D>N No ClinGen
TOPMed
rs756093210
CA9352189
81 E>D No ClinGen
ExAC
gnomAD
rs1292366571
CA405261781
82 D>G No ClinGen
TOPMed
CA9352190
rs147120845
83 D>H No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs777793550
CA9352193
85 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs758728524
CA9352192
85 R>W No ClinGen
ExAC
gnomAD
rs1232451679
CA405261853
88 P>R No ClinGen
gnomAD
rs1431148904
CA405261858
89 N>D No ClinGen
gnomAD
TCGA novel 90 S>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA9352194
rs747414395
91 T>A No ClinGen
ExAC
gnomAD
CA405261898
rs1344543517
91 T>M No ClinGen
gnomAD
CA9352198
rs770236821
95 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA9352197
COSM48272
rs574899763
95 R>W lung urinary_tract [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
gnomAD
rs867465231
CA307136316
98 A>V No ClinGen
Ensembl
rs775011048
CA9352199
99 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA9352201
rs141027304
101 R>S No ClinGen
1000Genomes
ExAC
gnomAD
rs368948662
CA405262058
103 S>C No ClinGen
ESP
ExAC
gnomAD
rs368948662
CA9352202
103 S>F No ClinGen
ESP
ExAC
gnomAD
rs1490189851
CA405262083
104 P>L No ClinGen
gnomAD
rs771807268
CA9352204
105 L>M No ClinGen
ExAC
TOPMed
gnomAD
rs1599599505
CA405262108
107 V>I No ClinGen
Ensembl
TCGA novel 111 A>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs904766205
CA307136327
111 A>G No ClinGen
TOPMed
CA9352230
rs201199358
116 V>A No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA9352232
rs767658103
118 K>E No ClinGen
ExAC
gnomAD
rs1568368859
CA405262418
122 N>D No ClinGen
Ensembl
rs1315717726
CA405262445
123 K>N No ClinGen
gnomAD
TCGA novel 125 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 125 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs200523129
CA9352234
130 D>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1336059359
CA405262500
131 Q>E No ClinGen
gnomAD
CA405262522
rs1357714062
134 L>I No ClinGen
Ensembl
CA405262548
rs1599599743
137 H>P No ClinGen
Ensembl
CA405262551
rs1324823402
137 H>Q No ClinGen
TOPMed
CA307136328
rs973067352
139 L>P No ClinGen
TOPMed
CA405262579
rs1286018059
142 P>Q No ClinGen
TOPMed
gnomAD
CA405262580
rs1286018059
142 P>R No ClinGen
TOPMed
gnomAD
CA307136329
rs918480017
142 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1315133523
CA405262586
143 K>R No ClinGen
gnomAD
CA405262594
rs1357077075
144 M>T No ClinGen
gnomAD
rs113246237
CA9352237
147 I>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 149 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 150 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA9352239
rs747657093
153 M>T No ClinGen
ExAC
gnomAD
rs778311875
CA9352238
153 M>V No ClinGen
ExAC
gnomAD
CA9352259
rs752164684
155 V>M No ClinGen
ExAC
gnomAD
CA9352261
rs777419186
158 V>I No ClinGen
ExAC
gnomAD
rs1306252772
CA405263373
159 Y>C No ClinGen
gnomAD
rs1372700367
CA405263381
160 K>R No ClinGen
gnomAD
CA9352264
rs781162822
162 H>Q No ClinGen
ExAC
gnomAD
CA9352265
rs138463303
164 E>D No ClinGen
ESP
ExAC
TOPMed
CA405263448
rs1368666276
170 Q>* No ClinGen
TOPMed
gnomAD
CA405263489
rs1352565996
175 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA9352268
rs372635299
178 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA307136725
rs761652754
187 L>V No ClinGen
Ensembl
rs1165447822 188 L>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA405263600
rs1221326568
191 I>T No ClinGen
gnomAD
rs760913241
CA9352271
193 I>V No ClinGen
ExAC
gnomAD
rs1199263662
CA405263674
202 L>R No ClinGen
gnomAD
CA9352290
rs149261350
206 Y>C No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs534391061
CA9352289
206 Y>H No ClinGen
1000Genomes
ExAC
gnomAD
CA9352291
rs747029180
207 P>L No ClinGen
ExAC
gnomAD
rs771158585
CA9352292
209 K>E No ClinGen
ExAC
gnomAD
rs571092461
CA9352293
209 K>N No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 211 H>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA9352295
rs770236070
211 H>Y No ClinGen
ExAC
gnomAD
CA405263753
rs1292984158
212 Q>H No ClinGen
TOPMed
CA9352296
COSM1200155
rs146187350
214 A>V large_intestine [Cosmic] No ClinGen
cosmic curated
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA405263771
rs1483549705
215 Y>F No ClinGen
gnomAD
TCGA novel 215 Y>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA405263807
rs1245069996
220 A>V No ClinGen
TOPMed
gnomAD
CA881271868
rs1439885543
221 C>* No ClinGen
TOPMed
TCGA novel 221 C>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1259738407
CA405263811
221 C>Y No ClinGen
TOPMed
gnomAD
CA9352299
rs751127659
224 D>N No ClinGen
ExAC
gnomAD
rs1462598632
CA405263861
228 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1034996209
CA307136828
229 M>V No ClinGen
TOPMed
gnomAD
rs1460807723
CA405263906
231 L>F No ClinGen
TOPMed
gnomAD
CA405263926
rs1254177499
232 M>I No ClinGen
TOPMed
gnomAD
rs766930038
CA9352301
232 M>T No ClinGen
ExAC
gnomAD
CA307136830
rs34609353
233 I>M No ClinGen
TOPMed
CA307136831
rs868405846
234 M>I No ClinGen
TOPMed
rs750127967
CA9352302
235 K>E No ClinGen
ExAC
gnomAD
CA405264077
rs1568371142
238 K>T No ClinGen
Ensembl
CA405264110
rs1411284279
240 R>C No ClinGen
gnomAD
rs146040933
CA9352329
240 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1299928139
CA405264145
242 S>N No ClinGen
TOPMed
rs1217245270
CA405264176
245 T>S No ClinGen
gnomAD
rs1430110442
CA405264185
246 I>V No ClinGen
TOPMed
gnomAD
rs1303375022
CA405264192
247 V>M No ClinGen
gnomAD
rs1312700382
CA405264230
250 L>M No ClinGen
gnomAD
CA405264258
rs1286820236
251 N>K No ClinGen
TOPMed
rs1363636644
CA405264256
251 N>S No ClinGen
TOPMed
TCGA novel 253 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs947197915
CA307136841
254 M>I No ClinGen
Ensembl
rs1418732142
CA405264285
254 M>L No ClinGen
TOPMed
rs745896656
CA9352330
254 M>T No ClinGen
ExAC
gnomAD
CA9352332
rs780481546
258 Y>C No ClinGen
ExAC
gnomAD
CA9352331
rs780422969
258 Y>H No ClinGen
ExAC
TOPMed
gnomAD
CA307136843
rs991552541
260 N>D No ClinGen
TOPMed
CA9352334
rs61750863
260 N>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA405264421
rs1427947159
263 H>R No ClinGen
gnomAD
CA405264415
rs1378454959
263 H>Y No ClinGen
gnomAD
CA9352335
rs150760804
266 L>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 267 L>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs189673443
CA9352338
268 P>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA9352337
rs189673443
268 P>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA9352339
rs760050164
269 Q>R No ClinGen
ExAC
gnomAD
TCGA novel 275 F>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA405264590
rs765901803
275 F>L No ClinGen
ExAC
TOPMed
gnomAD
CA405264601
rs1295061842
276 I>T No ClinGen
TOPMed
gnomAD
rs550305011
CA307136844
279 A>V No ClinGen
1000Genomes
CA9352359
rs776097311
281 L>Q No ClinGen
ExAC
gnomAD
CA9352361
rs764831974
282 L>M No ClinGen
ExAC
gnomAD
rs775361688
CA9352363
283 D>N No ClinGen
ExAC
gnomAD
rs201564787
CA307136850
284 L>P No ClinGen
1000Genomes
CA405264722
rs1352102312
288 D>H No ClinGen
Ensembl
rs1208466533
CA405264741
290 D>E No ClinGen
TOPMed
gnomAD
CA9352364
rs762712656
290 D>N No ClinGen
ExAC
gnomAD
rs763943099
CA9352365
291 C>S No ClinGen
ExAC
gnomAD
CA405264766
rs1466631417
294 F>Y No ClinGen
gnomAD
CA9352366
rs139792204
295 P>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA405264791
rs1249477312
298 I>V No ClinGen
TOPMed
gnomAD
CA405264811
rs1196239973
301 A>S No ClinGen
TOPMed
CA405264820
rs1449890888
302 S>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA9352370
rs369422968
305 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA9352371
rs779222474
308 S>L No ClinGen
ExAC
TOPMed
gnomAD
rs1231827332
CA405264872
310 S>C No ClinGen
TOPMed
rs1231827332
CA405264873
310 S>Y No ClinGen
TOPMed
rs752953807
CA9352372
312 L>S No ClinGen
ExAC
gnomAD
rs758760456
CA9352373
313 M>L No ClinGen
ExAC
gnomAD
rs1333385090
CA405264911
315 K>N No ClinGen
gnomAD
CA405264939
rs1399940029
318 G>A No ClinGen
gnomAD
CA9352374
rs778173124
318 G>R No ClinGen
ExAC
gnomAD
TCGA novel 321 W>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1252378705
CA405264964
321 W>C No ClinGen
Ensembl
rs1023028166
CA307136855
321 W>R No ClinGen
TOPMed
rs757767972
CA9352394
323 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA405264988
rs1286644454
325 E>K No ClinGen
gnomAD
rs544560032
CA9352395
328 V>I No ClinGen
ExAC
gnomAD
rs746367838
CA307136856
329 K>N No ClinGen
ExAC
TOPMed
gnomAD
CA405265034
rs1280438075
331 M>L No ClinGen
gnomAD
rs769332791
CA9352397
332 V>A No ClinGen
ExAC
gnomAD
CA405265045
rs769332791
332 V>G No ClinGen
ExAC
gnomAD
TCGA novel 333 P>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1253496863
CA405265056
334 F>S No ClinGen
gnomAD
TCGA novel 335 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA405265071
rs1599604412
336 M>I No ClinGen
Ensembl
rs748914866
COSM1392408
CA9352399
336 M>V Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs768311443
CA9352400
338 I>M No ClinGen
ExAC
gnomAD
CA405265086
rs1375913707
339 R>G No ClinGen
gnomAD
rs1375913707
CA405265087
339 R>W No ClinGen
gnomAD
rs200042616
CA9352401
341 T>M No ClinGen
ExAC
TOPMed
gnomAD
rs1395798003
CA405265108
342 G>R No ClinGen
gnomAD
TCGA novel 344 S>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA405265122
rs1306461910
344 S>P No ClinGen
gnomAD
rs773352937
CA9352404
345 K>N No ClinGen
ExAC
TOPMed
gnomAD
CA405265147
rs1392404768
348 H>D No ClinGen
gnomAD
rs760662828
CA9352405
348 H>Q No ClinGen
ExAC
gnomAD
rs1056559593
CA307136857
350 R>G Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA9352406
rs377334228
351 G>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA405265174
rs1304746106
352 V>F No ClinGen
gnomAD
CA405265172
rs1304746106
352 V>I No ClinGen
gnomAD
COSM439172
CA405265178
rs1225502237
353 A>T Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
rs1276415127
CA405265200
356 D>N No ClinGen
gnomAD
CA405265219
rs1386011056
358 H>Q No ClinGen
TOPMed
rs751936036
CA9352410
358 H>Y No ClinGen
ExAC
TOPMed
gnomAD
rs1208809143
CA405265222
359 N>D No ClinGen
gnomAD
TCGA novel 360 I>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA307136859
rs748789990
360 I>V No ClinGen
Ensembl
CA9352412
rs767834371
364 R>G No ClinGen
ExAC
gnomAD
CA9352413
rs750976115
366 S>N No ClinGen
ExAC
gnomAD
rs756562829
CA9352414
367 L>F No ClinGen
ExAC
TOPMed
gnomAD
CA405265303
rs1448987129
370 L>R No ClinGen
gnomAD
CA405265332
rs1568372322
373 A>T No ClinGen
Ensembl
rs368180317
CA9352434
COSM3742882
374 R>Q liver [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
rs754580480
CA9352435
375 A>P No ClinGen
ExAC
gnomAD
TCGA novel 376 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA9352436
rs778537865
377 K>Q No ClinGen
ExAC
gnomAD
CA405265364
rs1463404926
378 A>S No ClinGen
gnomAD
CA9352439
rs758079121
379 M>I No ClinGen
ExAC
TOPMed
gnomAD
CA9352438
rs747856215
379 M>T No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 379 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs777743353
CA9352440
382 E>* No ClinGen
ExAC
gnomAD
TCGA novel 388 P>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs776690668
CA9352443
389 L>P No ClinGen
ExAC
gnomAD
CA9352446
rs774365725
391 S>R No ClinGen
ExAC
rs184647504
CA9352445
391 S>T No ClinGen
1000Genomes
ExAC
gnomAD
rs762053632
CA9352447
393 L>P No ClinGen
ExAC
gnomAD
CA9352448
rs772211604
394 L>F No ClinGen
ExAC
gnomAD
CA9352449
rs773575462
394 L>P No ClinGen
ExAC
rs766646576
CA9352451
395 T>P No ClinGen
ExAC
gnomAD
CA9352455
rs764865470
400 G>R No ClinGen
ExAC
TOPMed
gnomAD
CA9352454
rs764865470
400 G>S No ClinGen
ExAC
TOPMed
gnomAD
rs1027875778
CA307136986
400 G>V No ClinGen
Ensembl
CA405265518
rs1254403211
402 K>N No ClinGen
gnomAD
CA9352457
rs777510598
406 G>E No ClinGen
ExAC
gnomAD
CA307136987
rs926232732
406 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
COSM186227
rs147896943
CA9352459
407 P>L Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs751159799
CA9352458
407 P>T No ClinGen
ExAC
gnomAD
rs141578348
CA9352461
COSM186228
410 A>V Variant assessed as Somatic; 0.0 impact. large_intestine prostate [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD

No associated diseases with P24864

3 regional properties for P24864

Type Name Position InterPro Accession
domain Cyclin, C-terminal domain 244 - 366 IPR004367
domain Cyclin, N-terminal 115 - 242 IPR006671
domain Cyclin-like domain 150 - 235 IPR013763

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
centrosome A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle.
cyclin E1-CDK2 complex A protein complex consisting of cyclin E1 and cyclin-dependent kinase 2 (CDK2). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle. Cyclin-dependent kinases represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner.
cyclin-dependent protein kinase holoenzyme complex Cyclin-dependent protein kinases (CDKs) are enzyme complexes that contain a kinase catalytic subunit associated with a regulatory cyclin partner.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

3 GO annotations of molecular function

Name Definition
cyclin-dependent protein serine/threonine kinase regulator activity Modulates the activity of a cyclin-dependent protein serine/threonine kinase, enzymes of the protein kinase family that are regulated through association with cyclins and other proteins.
kinase activity Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
protein kinase binding Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.

12 GO annotations of biological process

Name Definition
cell division The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells.
DNA replication initiation The process in which DNA-dependent DNA replication is started; this begins with the ATP dependent loading of an initiator complex onto the DNA, this is followed by DNA melting and helicase activity. In bacteria, the gene products that enable the helicase activity are loaded after the initial melting and in archaea and eukaryotes, the gene products that enable the helicase activity are inactive when they are loaded and subsequently activate.
G1/S transition of mitotic cell cycle The mitotic cell cycle transition by which a cell in G1 commits to S phase. The process begins with the build up of G1 cyclin-dependent kinase (G1 CDK), resulting in the activation of transcription of G1 cyclins. The process ends with the positive feedback of the G1 cyclins on the G1 CDK which commits the cell to S phase, in which DNA replication is initiated.
homologous chromosome pairing at meiosis The meiotic cell cycle process where side by side pairing and physical juxtaposition of homologous chromosomes is created during meiotic prophase. Homologous chromosome pairing begins when the chromosome arms begin to pair from the clustered telomeres and ends when synaptonemal complex or linear element assembly is complete.
mitotic cell cycle phase transition The cell cycle process by which a cell commits to entering the next mitotic cell cycle phase.
negative regulation of transcription by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
positive regulation of mesenchymal stem cell proliferation Any process that activates or increases the frequency, rate or extent of mesenchymal stem cell proliferation.
protein phosphorylation The process of introducing a phosphate group on to a protein.
regulation of cyclin-dependent protein serine/threonine kinase activity Any process that modulates the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity.
regulation of protein localization Any process that modulates the frequency, rate or extent of any process in which a protein is transported to, or maintained in, a specific location.
telomere maintenance Any process that contributes to the maintenance of proper telomeric length and structure by affecting and monitoring the activity of telomeric proteins, the length of telomeric DNA and the replication and repair of the DNA. These processes includes those that shorten, lengthen, replicate and repair the telomeric DNA sequences.
Wnt signaling pathway The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.

16 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P20438 CLN2 G1/S-specific cyclin CLN2 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
P24869 CLB2 G2/mitotic-specific cyclin-2 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
P41002 CCNF Cyclin-F Homo sapiens (Human) PR
O95067 CCNB2 G2/mitotic-specific cyclin-B2 Homo sapiens (Human) PR
P30279 CCND2 G1/S-specific cyclin-D2 Homo sapiens (Human) PR
Q6ZMN8 CCNI2 Cyclin-I2 Homo sapiens (Human) PR
Q61457 Ccne1 G1/S-specific cyclin-E1 Mus musculus (Mouse) PR
Q10PQ9 SDS Cyclin-SDS-like Oryza sativa subsp japonica (Rice) PR
Q0JIF2 CYCB1-1 Cyclin-B1-1 Oryza sativa subsp japonica (Rice) PR
Q10Q62 CYCF3-2 Putative cyclin-F3-2 Oryza sativa subsp japonica (Rice) PR
O48790 CYCB1-4 Cyclin-B1-4 Arabidopsis thaliana (Mouse-ear cress) PR
A0MEB5 CYCA3-3 Cyclin-A3-3 Arabidopsis thaliana (Mouse-ear cress) PR
Q9FMH5 CYCA3-1 Putative cyclin-A3-1 Arabidopsis thaliana (Mouse-ear cress) PR
Q1PFW3 SDS Cyclin-SDS Arabidopsis thaliana (Mouse-ear cress) PR
Q9C6A9 CYCA3-2 Cyclin-A3-2 Arabidopsis thaliana (Mouse-ear cress) PR
P47794 ccne1 G1/S-specific cyclin-E1 Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MPRERRERDA KERDTMKEDG GAEFSARSRK RKANVTVFLQ DPDEEMAKID RTARDQCGSQ
70 80 90 100 110 120
PWDNNAVCAD PCSLIPTPDK EDDDRVYPNS TCKPRIIAPS RGSPLPVLSW ANREEVWKIM
130 140 150 160 170 180
LNKEKTYLRD QHFLEQHPLL QPKMRAILLD WLMEVCEVYK LHRETFYLAQ DFFDRYMATQ
190 200 210 220 230 240
ENVVKTLLQL IGISSLFIAA KLEEIYPPKL HQFAYVTDGA CSGDEILTME LMIMKALKWR
250 260 270 280 290 300
LSPLTIVSWL NVYMQVAYLN DLHEVLLPQY PQQIFIQIAE LLDLCVLDVD CLEFPYGILA
310 320 330 340 350 360
ASALYHFSSS ELMQKVSGYQ WCDIENCVKW MVPFAMVIRE TGSSKLKHFR GVADEDAHNI
370 380 390 400
QTHRDSLDLL DKARAKKAML SEQNRASPLP SGLLTPPQSG KKQSSGPEMA